Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ.

Devro Plc engages in the manufacture of collagen and sausage casings products for the food industry. It operates through the following geographical segments: Americas, Asia-Pacific, Europe, and Global. The Americas segment includes North America and Latin America. The Asia-Pacific segment comprises of Australia, New Zealand, Japan, China and the rest of South East Asia. The Europe segment consists of Continental Europe, United Kingdom, Ireland, and Africa. The company was founded in 1962 and is headquartered in Glasgow, the United Kingdom.

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.

WorldHeart is a public company headquartered in Salt Lake City, Utah (USA), with additional offices located in Oakland, California (USA), and in Herkenbosch (The Netherlands). Its registered office is Delaware, USA. Its stock trades on the NASDAQ National Market (ticker symbol: WHRT).

Shirako Co. Ltd. is a private company headquartered in Japan, with operations in the United States. The firm prepares and sells canned food products.

FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. The company applies its pioneering expertise in hypoxia-inducible factor (HIF), connective tissue growth factor (CTGF) biology, and clinical development to advance innovative medicines for the treatment of anemia, fibrotic disease, and cancer. FibroGen's product Roxadustat is an oral small-molecule inhibitor of HIF prolyl hydroxylase activity in worldwide Phase 3 clinical development for the treatment of anemia in chronic kidney disease (CKD), with a New Drug Application currently under review in China by the State Drug Administration or SDA (formerly the China Food and Drug Administration).

Hubei Ruibang Biotechnology Co., Ltd., established on 2007-12-26, Business scope includes food,beverage production,processing,Sales;Pre-packaged food,Wholesale and retail of cosmetics;Self-operated and agent goods and technology import and export business(Does not contain goods and technologies prohibited or restricted by the state);road general cargo transportation.##(Involved in licensing projects,It should be operated after obtaining the permission of the relevant department)

Qinghai Reitide Biotechnology Co., Ltd., established on 2019-09-26, Business scope includes animal and plant small molecules,Peptide and protein extracts and related products,Research and development of end products,Promotion of packaging and related technologies;Acquisition and sale of agricultural and livestock products;Commodity Trading Using the Internet.(Involved in licensing projects,It should be operated after obtaining the permission of the relevant department)

Isolagen Technologies, Inc. researches and develops cellular technology. specializes in the development and commercialization of autologous cellular system. The company is headquartered in Houston, TX.

Welland Medical Ltd., a subsidiary of Medical Depot, Inc., is a British company located in Crawley that manufactures homecare equipment and mobility products. It was founded in 1988. Christopher Donald Primett is the current CEO, occupying that position since 2002. Welland Medical Ltd. was acquired by Drive Devilbiss Healthcare Ltd. on March 17, 2011.\nThe company says this about itself: Welland Medical is an innovator in stoma care; specialising in the design, development and manufacture of stoma care appliances and accessories, using the highest quality materials. Welland Medical is a British manufacturing company established in 1988 and one of the leading ostomy brands in the UK and worldwide.

Suzhou Wenda Food Ingredients Co., Ltd, established on 2009-02-16, The business scope includes the production of food additives,processing,Sales;seasoning(solid state),drinks(Solid beverage),soy products,other food(powder coating,pastry mix)Production;food sales(according to<food business license>Approved project management);Import and export business of goods and technology.(The law in the aforementioned business items,Administrative regulations stipulate pre-licensing operations,restricted operation,Except for prohibited operations)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nitta Casings, Inc. provides collagen solutions. Its products include edible collagen sausage casings, collagen pastes and doughs and sausage linking equipment. The company was founded in 1996 and is headquartered in Bridgewater, NJ.

Baotou Dongbao Bio-Tech is a joint-stock firm that is involved in the development, production, and marketing of low molecular mass collagen and products from the gelatin series. The Company principally provides gelatin, which is used in the creation of empty capsules and food additives; calcium pyrophosphate, which is used in feed additives, as well as collagen series products, which are used in foods, cosmetics, and health care goods. Both domestic and foreign markets are served by the company's distribution of its products.

Anhui Zaitian Ecological Agriculture Development Co., Ltd., established on 2015-07-24, Business scope includes agricultural technology development,Technical Services,technology transfer,technical consulting;Agricultural Information Consulting Service;crop planting,First Processing,Sales;flowers,Seedling planting,Sales;aquaculture,Sales;Landscaping Engineering Services;Farmland mechanization service;Ecological farm management planning service;Circulation of rural land contract management rights;Provide leisure and sightseeing,fishing service.***

Shandong Hengxin Biotechnology Co., Ltd., established on 2005-10-18, Business scope includes research and development of food additive gelatin,Production,Sales;medical supplements(gelatin for capsules)research and development,Production,Sales;industrial grease(animal oil,Flash point greater than60ºC)Production,Sales;hydrolyzed gelatin,Hydrolyzed Collagen,Research and development of gelatin derivatives,Production,Sales;vegetable gelatin sales;Import and export business within the scope of filing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shenzhen Hanshow Jianyuan Biotechnology Co., Ltd., established on 2018-03-08, Business scope includes general business items:Health products,Nursing products,daily necessities,food,Technology development of condiments,meat(beef,pork,chicken,Mutton etc.)import and sale of;Operating import and export business(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating);engaged in industrial design,Computer software design, development and consulting(No restricted items).,The licensing program is:research and development,Production,Sales of biological products;Health products,Nursing products,daily necessities,food,Technology development of condiments,meat(beef,pork,chicken,Mutton etc.)of domestic processing.

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Acceleron Pharma, Inc. operates as a biopharmaceutical company. The company engages in developing, manufacturing, and commercializing novel biotherapeutics that modulate the growth of bone, muscle, fat, and the vasculature to treat musculoskeletal, metabolic, and cancer-related diseases. Its products include ACE-011 Program, a novel bone forming agent that helps to treat cancer-related bone loss; ACE-031 Program that helps to treat diseases involving the loss of muscle mass, strength, and function in diseases, including muscular dystrophy, amyotrophic lateral sclerosis, and cancer-related muscle loss; and ACE-041, a protein therapeutic that binds a member of the growth and differentiation factor family necessary for angiogenesis. It develops therapies based on growth and differentiation factors that regulate the cellular proliferation, differentiation, and survival of a range of tissue types. The company offers treatments for cancer-related bone loss, cancer-related muscle loss, neuromuscular diseases, and metabolic disorders. Acceleron Pharma, Inc. was founded in 2003 and is headquartered in Cambridge, Massachusetts.

Part of Cathay International Holdings Ltd., Changchun Botai Medicine Biotechnology Co., Ltd. is a company headquartered in Changchun, China. The firm manufactures and supplies health products and medical equipment.